|
|
|||||||||||
The British Journal of Psychiatry 150: 653-655 (1987)
© 1987 The Royal College of Psychiatrists
S Levine, R Deo and K Mahadevan
Oldham and District General Hospital.
This clinical trial of a new antidepressant, fluoxetine, shows it to be as effective as a standard tricyclic drug, imipramine. It is effective as a single daily dose and is free of any significant side-effects. It is less sedative and appears to cause fewer problems of weight increase. The three scales used to assess efficacy showed a very positive correlation.
This article has been cited by other articles:
![]() |
I M Anderson and B M Tomenson Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis BMJ, June 3, 1995; 310(6992): 1433 - 1438. [Abstract] [Full Text] |
||||
![]() |
L. F. Gram Fluoxetine N. Engl. J. Med., November 17, 1994; 331(20): 1354 - 1361. [Full Text] |
||||
![]() |
I.M. Anderson and B.M. Tomenson The efficacy of selective serotonin re-uptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants J Psychopharmacol, January 1, 1994; 8(4): 238 - 249. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Psychiatric Bulletin | Advances in Psychiatric Treatment | All RCPsych Journals |